I’ve seen some “positive posts” about valua
Post# of 148174
Meaning that I know My investment with CYDY is extremely safe so to the fact HIV is already at the finishline, CD-10 could have had an approval with a phase 3 trial however manufacturing and supplies would have been a major issue, long haulers trial will be starting in next couple
Weeks. If we ever didn’t meet FDA standard PValue for full approval for Covid severe critical we all know that the numbers more than exceed an EUA pretty immediately. Than there are the 25+ other indications that will easily be able to be funded and filled quicker now that doctors are becoming more familiar with Leronlimab and MAB’s in general. It’s not a question is this investment going to go way up in multiples of current SP the 2 main question are how fast and How high can she fly. GLTA going to bed very exciting New Years